Completed NA INTERVENTIONAL 5-arm NCT04058054

Skin Prick Test of KeraStat® Cream

Sponsor: KeraNetics, LLC

Interventions Biafine Histamine KeraStat Gel KeraStat® Cream Saline (0.9% NaCl)

Updated 8 times since 2019 Last updated: Oct 19, 2022 Started: Jul 29, 2019 Primary completion: Aug 2, 2019 Completion: Aug 2, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04058054, this NA trial focuses on Hypersensitivity and remains completed. Sponsored by KeraNetics, LLC, it has been updated 8 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Sep 2022 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2021 — Sep 2022 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA
Sep 2019 — Feb 2020 [monthly]

Completed NA

First recorded

Jul 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KeraNetics, LLC

Data source: KeraNetics, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winston-Salem, United States